Patents by Inventor Thomas V. Riley

Thomas V. Riley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial compounds
    Patent number: 10696620
    Abstract: Disclosed herein are compounds for use as antimicrobial agents, having a structure of formula (I):
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: June 30, 2020
    Assignee: Boulos & Cooper Pharmaceuticals Pty Ltd
    Inventors: Allan James McKinley, Thomas V. Riley, Nigel Lengkeek, Scott Stewart, Ramiz Boulos
  • ANTIMICROBIAL COMPOUNDS
    Publication number: 20180290963
    Abstract: Disclosed herein are compounds for use as antimicrobial agents, having a structure of formula (I):
    Type: Application
    Filed: April 5, 2018
    Publication date: October 11, 2018
    Inventors: Allan James McKinley, Thomas V. Riley, Nigel Lengkeek, Scott Stewart, Ramiz Boulos
  • Antimicrobial compounds
    Patent number: 9023892
    Abstract: A compound for use as an antimicrobial having a formula (A).
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: May 5, 2015
    Inventors: Allan James McKinley, Thomas V. Riley, Nigel Lengkeek, Scott Stewart, Ramiz Boulos
  • ANTIMICROBIAL COMPOUNDS
    Publication number: 20120329871
    Abstract: A compound for use as an antimicrobial having a formula (A).
    Type: Application
    Filed: December 21, 2010
    Publication date: December 27, 2012
    Applicant: THE UNIVERSITY OF WESTERN AUSTRALIA
    Inventors: Allan James McKinley, Thomas V. Riley, Nigel Lengkeek, Scott Stewart, Ramiz Boulos
  • Compositions Comprising Tea Tree Oil and Methods for the Prevention and Treatment of Cancer
    Publication number: 20110293757
    Abstract: Compositions for the treatment and/or prevention of cancer are described. Preferably the composition comprises a therapeutically effective amount of tea tree oil from Melaleuca alternifolia, together with a pharmaceutically or therapeutically acceptable carrier and/or diluent. Methods for the treatment and/or prevention of cancer are also described. Preferably the method is used for the treatment and prevention of skin cancer. More preferably, the method is used for the treatment and prevention of basal cell carcinoma, squamous cell carcinoma and/or melanoma.
    Type: Application
    Filed: July 17, 2009
    Publication date: December 1, 2011
    Applicant: Novasel Australia Pty. Ltd.
    Inventors: Thomas V. Riley, Sara J. Greay, Christine F. Carson, Manfred W. Beilharz, Demelza J. Ireland, Haydn T. Kissick